EIR Ventures — Full Portfolio

Moleculent develops biological discovery and disease understanding tools for scientists.

AI & Machine LearningBiotechDeep TechSolna, SE

FRFredrik Roos(CTO & Co-founder)in

Co-investorsARARCH Venture Partners

Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.

BiotechDeep TechHealthtechMedical Devices

MMMichal Minczuk(Co-Founder)inGMGabriel Martinez(Chief Scientific Officer & Co-Founder)CGClaes Gustafsson(Co-Founder)MFMaria Falkenberg(Co-Founder)NLNils-Göran Larsson(Co-Founder)Gabriel Martinez, Ph.D.(Chief Scientific Officer & Co-Founder)

Co-investorsARARCH Venture PartnersCACambridge Innovation CapitalANAngelini VenturesGVGV (Google Ventures)HEHealthCapINInvus+2 more

Strike Pharma develops nanoparticle delivery technology to enable the development of in vivo CAR therapies.

BiotechDeep TechHealthtechLongevityMedical DevicesStockholm, SE

Sara Mangsbo(Founder)Johan Rockberg(Co-founder)Per Norlén(Chief Executive Officer)Tina Furebring(Chief Operations Officer)

Co-investorsALAlmi Invest

ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing.

BiotechDeep TechHardware

Co-investorsVOVoima Ventures

ArgusEye builds autonomous AI engineers for product security in cyber-physical systems, operating inside R&D and engineering teams to model threats, prescribe security controls, and generate audit-ready evidence.

AI & Machine LearningCybersecurityDeep TechSan Francisco, US

Jackson Schultz(Co-founder & CEO)inLILawrence Ibarria(Co-Founder & CTO)inW. Jackson Schultz(Co-Founder & CEO)in

Co-investorsCICIVPRPredictive VCVOVoima Ventures

Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients.

BiotechDigital HealthHealthtechMedical DevicesStockholm, SE

Lars E. Gustafsson(Co-founder (deceased))

BoardMPMagnus Persson(Chairman of the Board)

Co-investorsHAHadean Ventures

Cinclus Pharma is a clinical-stage pharmaceutical company developing small molecule treatments for gastric acid-related disorders, with its lead compound targeting severe gastroesophageal reflux disease.

BiotechDigital HealthHealthtechMedical Devices

Christer Ahlberg(CEO)

Entrilia provides an integrated platform supporting the complete lifecycle of fund operations, including financial reporting, investor management, and operational workflows for fund managers.

AI & Machine LearningEnterprise SoftwareFintechSaaS

EFEric Faw(Founder)in

Co-investorsHUHumble GrowthWAWatertower Ventures Management, Llc

Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.

BiotechMedical Devices

JJJennifer Jarrett(Chief Executive Officer & Board Director)inSSSherwin Sattarzadeh(Chief Operating Officer)inBHBecker Hewes(Chief Medical Officer)GWGarrett Winslow(General Counsel)inJBJim Baker(Chief Corporate Affairs Officer)inBBBrian Burkavage(Senior Vice President, Finance)in

Co-investorsHAHadean VenturesM M VenturesSESEED Capital DenmarkSESeventure PartnersSUSunstone CapitalYSYsios Capital+3 more

Gutcrine is a Danish biotech developing pharmabiotics derived from gut microbiome hormone synthesis, aimed at the prevention and treatment of cardio-metabolic disorders.

BiotechDeep TechHealthtechLongevityCopenhagen, DK

OPOluf Pedersen(CSO & Co-founder)YFYong Fan(COO & Co-founder)THTobias Horneman-Thielcke(CEO)in

Henlez is an early-stage biotech company working in the dermatology space.

BiotechHealthtech

Jeppe C. Mouritsen, PhD(Founding CEO)Gregor Jemec, MD(Co-founder & Chief Scientific Advisor)

Danish biotech developing non-opioid restorative treatments for chronic pain, hearing loss and sensory neuron disorders.

Co-investorsINIndaco Venture PartnersMEMedical Incubator Japan K.K.NONovo Holdings

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Dr. Dhingra

Co-investorsAVAvoro Capital AdvisorsKUKurma PartnersPIPivotal Life SciencesRARA CapitalSASamsara BioCapitalSUSunstone Capital+3 more

Purpose Pharma develops pharmaceutical treatments for rare genetic and metabolic diseases, with a focus on hereditary amyloidosis conditions.

BiotechHealthtechLongevityMedical DevicesStockholm, SE

Jonas Hansson(CEO, Co-founder)Jacob Gunterberg(CFO, Co-founder)Lars Olsson(COO, Co-founder)

Co-investorsINIndustrifonden

The page is a domain listing/marketplace tool (ExpiredDomains.com) that aggregates expired and expiring domain names across many TLDs and lets users filter them by SEO authority, keywords, backlinks, and brand potential.

Marketing TechSaaS

SACRA Therapeutics is a drug discovery company developing therapeutics that target the RNA epitranscriptome, with a focus on oncology.

BiotechHealthtechLund, SE

Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtech

Co-investorsBIBioGeneration VenturesBIBioMedPartnersINInkefOXOxford Science Enterprises

Sortina Pharma develops oral small molecule therapeutics targeting sortilin to treat life-threatening diseases, including cancers such as Glioblastoma Multiforme and neurodegenerative disorders.

BiotechHealthtechGothenburg, SE

Sara Rhost(Co-Founder & CEO)

Co-investorsGUGU Ventures AB